British Society for Rheumatology Biologics Register

A. Silman; D. Symmons; D. G. I. Scott; I. Griffiths

doi:10.1136/ard.62.suppl_2.ii28

British Society for Rheumatology Biologics Register

A. Silman, D. Symmons, D. G. I. Scott, I. Griffiths

Norwich Medical School

Research output: Contribution to journal › Article

68 Citations (Scopus)

Abstract

The British Society for Rheumatology (BSR) established a register of patients newly treated with biological agents, the BSR Biologics Register (BSRBR), which became active in January 2002. The goal is to register all patients in the United Kingdom with rheumatic diseases, newly starting treatment with these agents and to follow them up to determine the incidence of any short and long term hazards to health. The Register is also recruiting a comparison cohort of patients with rheumatoid arthritis treated with standard disease modifying antirheumatic drugs to determine the relative contributions of disease factors and other treatments apart from biological agents on any risks observed.

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	62
Issue number	Suppl 2
DOIs	https://doi.org/10.1136/ard.62.suppl_2.ii28
Publication status	Published - Nov 2003

Access to Document

10.1136/ard.62.suppl_2.ii28

Cite this

@article{897310d68ef44b8da1bf9ef0e7f89d7f,

title = "British Society for Rheumatology Biologics Register",

abstract = "The British Society for Rheumatology (BSR) established a register of patients newly treated with biological agents, the BSR Biologics Register (BSRBR), which became active in January 2002. The goal is to register all patients in the United Kingdom with rheumatic diseases, newly starting treatment with these agents and to follow them up to determine the incidence of any short and long term hazards to health. The Register is also recruiting a comparison cohort of patients with rheumatoid arthritis treated with standard disease modifying antirheumatic drugs to determine the relative contributions of disease factors and other treatments apart from biological agents on any risks observed.",

author = "A. Silman and D. Symmons and Scott, {D. G. I.} and I. Griffiths",

year = "2003",

month = nov,

doi = "10.1136/ard.62.suppl_2.ii28",

language = "English",

volume = "62",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "Suppl 2",

}

TY - JOUR

T1 - British Society for Rheumatology Biologics Register

AU - Silman, A.

AU - Symmons, D.

AU - Scott, D. G. I.

AU - Griffiths, I.

PY - 2003/11

Y1 - 2003/11

N2 - The British Society for Rheumatology (BSR) established a register of patients newly treated with biological agents, the BSR Biologics Register (BSRBR), which became active in January 2002. The goal is to register all patients in the United Kingdom with rheumatic diseases, newly starting treatment with these agents and to follow them up to determine the incidence of any short and long term hazards to health. The Register is also recruiting a comparison cohort of patients with rheumatoid arthritis treated with standard disease modifying antirheumatic drugs to determine the relative contributions of disease factors and other treatments apart from biological agents on any risks observed.

AB - The British Society for Rheumatology (BSR) established a register of patients newly treated with biological agents, the BSR Biologics Register (BSRBR), which became active in January 2002. The goal is to register all patients in the United Kingdom with rheumatic diseases, newly starting treatment with these agents and to follow them up to determine the incidence of any short and long term hazards to health. The Register is also recruiting a comparison cohort of patients with rheumatoid arthritis treated with standard disease modifying antirheumatic drugs to determine the relative contributions of disease factors and other treatments apart from biological agents on any risks observed.

U2 - 10.1136/ard.62.suppl_2.ii28

DO - 10.1136/ard.62.suppl_2.ii28

M3 - Article

VL - 62

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl 2

ER -